Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.
Tryptophan ethyl ester, a lipid-soluble tryptophan derivative, was used to bypass defective gastrointestinal neutral amino acid transport in a child with Hartnup disease. The child's baseline tryptophan concentrations in serum (20 +/- 6 microM) and cerebrospinal fluid (1.0 +/- 0.2 microM) were persi...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1989
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303970/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2472426/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114141 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|